Allergy Amulet develops a portable food allergen sensor that detects allergenic ingredients in food samples within one minute, providing results at levels lower than those known to trigger reactions in sensitive individuals. This technology addresses the critical need for real-time allergen detection, enhancing safety for people with food allergies.

Anjo.ai develops a remote monitoring system that utilizes AI and wearable technology to detect early signs of life-threatening allergic reactions in children. This solution provides parents with real-time physiological data and alerts, enabling timely intervention and potentially saving lives.

Bryn Pharma is developing a needle-free epinephrine nasal spray for the emergency treatment of anaphylaxis, addressing the challenges of current bulky autoinjectors that many patients are reluctant to use or carry. This portable and easy-to-administer device aims to improve accessibility and compliance for individuals at risk of severe allergic reactions.

The startup has developed a medical system that utilizes virtual reality-based distraction techniques to perform unsedated endoscopy procedures for pediatric and adult patients. This approach eliminates the need for anesthesia, thereby reducing the complexity, cost, and anxiety associated with traditional endoscopy methods.

Provides a dietary and nutrition app that uses barcode scanning and an extensive ingredient database to identify food products matching users' dietary restrictions, such as allergies, intolerances, or lifestyle choices. The app simplifies meal planning and grocery shopping by offering personalized food recommendations from over 50 stores, eliminating the need for manual ingredient checks.

The startup develops a robotic and AI-driven medical system that automates allergy testing, enabling healthcare professionals to diagnose allergic conditions more efficiently. This technology simplifies the identification of allergic patients, improving the accuracy and speed of chronic condition management.

IgGenix uses a proprietary single-cell RNA-sequencing platform, SEQ SIFTER™, to isolate and engineer fully human, high-affinity IgG antibodies that target immunodominant allergens, blocking the allergic cascade. This approach aims to develop safe, injectable therapies for food and environmental allergies, with the first candidate, IGNX001, currently in Phase 1 trials for peanut allergy.

Latitude Food Allergy Care operates clinics that utilize oral immunotherapy (OIT) and gold-standard allergy testing to create personalized treatment plans for children and adults with food allergies. The company addresses the challenges of managing food allergies by providing expert care and support, enabling patients to increase their tolerance to allergens and improve their quality of life.

Moonlight Therapeutics is developing MOON101, an intradermal therapy designed to desensitize individuals with peanut allergies through a brief application process. This treatment aims to provide a safe and effective solution for managing food allergies, improving the quality of life for patients.

Ready. Set. Food! provides a pediatrician‑developed, three‑stage system of pre‑measured, USDA‑certified organic allergen powders and foods that parents can mix into breast milk, formula, or solid foods from 4 months onward. The daily packets deliver the exact dosages proven in the LEAP and EAT studies to introduce peanut, egg, milk and later seven additional top allergens, helping infants build lasting tolerance while avoiding artificial additives.

The startup produces science-based baby food products that are fresh, nutrient-dense, and low in sugar, specifically designed to meet the dietary needs of infants and toddlers. By providing tailored meals and vitamins, the company ensures that children receive essential nutrition for optimal brain development during their critical early years.